Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2010-12-30

FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nortriptyline hydrochloride from Teva Pharmaceuticals USA, Inc., typically indicating a labeling change or other app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nortriptyline Hydrochloride (Nortriptyline hydrochloride)

Snippet

SUPPL AP for NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE HYDROCHLORIDE)